ID CLAP1_HUMAN Reviewed; 1538 AA. AC Q7Z460; A2RU21; B7ZLX3; F5GWS0; O75118; Q2KHQ9; Q5H9P0; Q8N5B8; Q9BQT5; DT 11-OCT-2005, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2003, sequence version 1. DT 27-MAR-2024, entry version 192. DE RecName: Full=CLIP-associating protein 1; DE AltName: Full=Cytoplasmic linker-associated protein 1; DE AltName: Full=Multiple asters homolog 1; DE AltName: Full=Protein Orbit homolog 1; DE Short=hOrbit1; GN Name=CLASP1; Synonyms=KIAA0622, MAST1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Maiato H., Sunkel C.E., Earnshaw W.C.; RT "Full length cDNA of a human homologue of Drosophila melanogaster multiple RT asters (MAST) gene."; RL Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 4 AND 5), AND RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1332-1538 (ISOFORMS 1/2). RC TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-266, FUNCTION, SUBCELLULAR LOCATION, RP ALTERNATIVE SPLICING, AND INTERACTION WITH CLIP2; MICROTUBULES AND RSN. RC TISSUE=Brain; RX PubMed=11290329; DOI=10.1016/s0092-8674(01)00288-4; RA Akhmanova A., Hoogenraad C.C., Drabek K., Stepanova T., Dortland B., RA Verkerk T., Vermeulen W., Burgering B.M., de Zeeuw C.I., Grosveld F., RA Galjart N.; RT "Clasps are CLIP-115 and -170 associating proteins involved in the regional RT regulation of microtubule dynamics in motile fibroblasts."; RL Cell 104:923-935(2001). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 221-1538 (ISOFORM 3). RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 250-1538. RC TISSUE=Brain; RX PubMed=9734811; DOI=10.1093/dnares/5.3.169; RA Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H., RA Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. X. The RT complete sequences of 100 new cDNA clones from brain which can code for RT large proteins in vitro."; RL DNA Res. 5:169-176(1998). RN [7] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=12837247; DOI=10.1016/s0092-8674(03)00465-3; RA Maiato H., Fairley E.A., Rieder C.L., Swedlow J.R., Sunkel C.E., RA Earnshaw W.C.; RT "Human CLASP1 is an outer kinetochore component that regulates spindle RT microtubule dynamics."; RL Cell 113:891-904(2003). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE RP ANALYSIS]. RC TISSUE=Lymphoblast; RX PubMed=14654843; DOI=10.1038/nature02166; RA Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.; RT "Proteomic characterization of the human centrosome by protein correlation RT profiling."; RL Nature 426:570-574(2003). RN [9] RP INTERACTION WITH MICROTUBULES, AND SUBCELLULAR LOCATION. RX PubMed=16145243; DOI=10.1247/csf.30.7; RA Aonuma M., Miyamoto M., Inoue Y.H., Tamai K., Sakai H., Kamasawa N., RA Matsukage A.; RT "Microtubule bundle formation and cell death induced by the human RT CLASP/Orbit N-terminal fragment."; RL Cell Struct. Funct. 30:7-13(2005). RN [10] RP FUNCTION, INTERACTION WITH MAPRE1; MAPRE3; MICROTUBULES AND RSN, AND RP SUBCELLULAR LOCATION. RX PubMed=15631994; DOI=10.1083/jcb.200405094; RA Mimori-Kiyosue Y., Grigoriev I., Lansbergen G., Sasaki H., Matsui C., RA Severin F., Galjart N., Grosveld F., Vorobjev I., Tsukita S., Akhmanova A.; RT "CLASP1 and CLASP2 bind to EB1 and regulate microtubule plus-end dynamics RT at the cell cortex."; RL J. Cell Biol. 168:141-153(2005). RN [11] RP INTERACTION WITH ERC1 AND PHLDB2, AND SUBCELLULAR LOCATION. RX PubMed=16824950; DOI=10.1016/j.devcel.2006.05.012; RA Lansbergen G., Grigoriev I., Mimori-Kiyosue Y., Ohtsuka T., Higa S., RA Kitajima I., Demmers J., Galjart N., Houtsmuller A.B., Grosveld F., RA Akhmanova A.; RT "CLASPs attach microtubule plus ends to the cell cortex through a complex RT with LL5beta."; RL Dev. Cell 11:21-32(2006). RN [12] RP FUNCTION. RX PubMed=16866869; DOI=10.1111/j.1365-2443.2006.00990.x; RA Mimori-Kiyosue Y., Grigoriev I., Sasaki H., Matsui C., Akhmanova A., RA Tsukita S., Vorobjev I.; RT "Mammalian CLASPs are required for mitotic spindle organization and RT kinetochore alignment."; RL Genes Cells 11:845-857(2006). RN [13] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=16914514; DOI=10.1091/mbc.e06-07-0579; RA Pereira A.L., Pereira A.J., Maia A.R.R., Drabek K., Sayas C.L., RA Hergert P.J., Lince-Faria M., Matos I., Duque C., Stepanova T., RA Rieder C.L., Earnshaw W.C., Galjart N., Maiato H.; RT "Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by RT regulating spindle and kinetochore function."; RL Mol. Biol. Cell 17:4526-4542(2006). RN [14] RP FUNCTION, INTERACTION WITH GCC2, AND SUBCELLULAR LOCATION. RX PubMed=17543864; DOI=10.1016/j.devcel.2007.04.002; RA Efimov A., Kharitonov A., Efimova N., Loncarek J., Miller P.M., RA Andreyeva N., Gleeson P., Galjart N., Maia A.R., McLeod I.X., RA Yates J.R. III, Maiato H., Khodjakov A., Akhmanova A., Kaverina I.; RT "Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at RT the trans-Golgi network."; RL Dev. Cell 12:917-930(2007). RN [15] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18220336; DOI=10.1021/pr0705441; RA Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III; RT "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient RT phosphoproteomic analysis."; RL J. Proteome Res. 7:1346-1351(2008). RN [16] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1196, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Platelet; RX PubMed=18088087; DOI=10.1021/pr0704130; RA Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., RA Schuetz C., Walter U., Gambaryan S., Sickmann A.; RT "Phosphoproteome of resting human platelets."; RL J. Proteome Res. 7:526-534(2008). RN [17] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600; SER-646; SER-649; RP THR-656; SER-688; SER-695; THR-711; SER-714; SER-1091 AND THR-1099, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [18] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [19] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600; SER-646; SER-688; RP SER-797 AND SER-1091, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [20] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-646 AND SER-1223, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [21] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [22] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600; SER-646 AND SER-684, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [23] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246; SER-545; SER-558; RP SER-559; SER-568; SER-600; SER-636; SER-646; SER-647; SER-649; SER-695; RP SER-705; SER-787; SER-797; SER-823; SER-1091 AND SER-1196, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [24] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [25] RP INTERACTION WITH MTCL2 AND MTCL1. RX PubMed=33587225; DOI=10.1007/s10577-021-09651-8; RA Ferreira L.T., Logarinho E., Macedo J.C., Maia A.R.R., Maiato H.; RT "SOGA1 and SOGA2/MTCL1 are CLASP-interacting proteins required for faithful RT chromosome segregation in human cells."; RL Chromosome Res. 29:159-173(2021). CC -!- FUNCTION: Microtubule plus-end tracking protein that promotes the CC stabilization of dynamic microtubules. Involved in the nucleation of CC noncentrosomal microtubules originating from the trans-Golgi network CC (TGN). Required for the polarization of the cytoplasmic microtubule CC arrays in migrating cells towards the leading edge of the cell. May act CC at the cell cortex to enhance the frequency of rescue of depolymerizing CC microtubules by attaching their plus-ends to cortical platforms CC composed of ERC1 and PHLDB2. This cortical microtubule stabilizing CC activity is regulated at least in part by phosphatidylinositol 3-kinase CC signaling. Also performs a similar stabilizing function at the CC kinetochore which is essential for the bipolar alignment of chromosomes CC on the mitotic spindle. {ECO:0000269|PubMed:11290329, CC ECO:0000269|PubMed:12837247, ECO:0000269|PubMed:15631994, CC ECO:0000269|PubMed:16866869, ECO:0000269|PubMed:16914514, CC ECO:0000269|PubMed:17543864}. CC -!- SUBUNIT: Interacts with CLIP2, ERC1, MAPRE1, MAPRE3, microtubules, CC PHLDB2 and RSN (PubMed:11290329, PubMed:16145243, PubMed:15631994, CC PubMed:16824950). The interaction with ERC1 may be mediated by PHLDB2 CC (PubMed:16824950). Interacts with GCC2; recruits CLASP1 to Golgi CC membranes (PubMed:17543864). Interacts with MACF1 (By similarity). CC Interacts with mtcl2 and MTCL1 (PubMed:33587225). CC {ECO:0000250|UniProtKB:Q80TV8, ECO:0000269|PubMed:11290329, CC ECO:0000269|PubMed:15631994, ECO:0000269|PubMed:16145243, CC ECO:0000269|PubMed:16824950, ECO:0000269|PubMed:17543864, CC ECO:0000269|PubMed:33587225}. CC -!- INTERACTION: CC Q7Z460; O60333: KIF1B; NbExp=3; IntAct=EBI-913476, EBI-465633; CC Q7Z460; P31947: SFN; NbExp=3; IntAct=EBI-913476, EBI-476295; CC Q7Z460; Q96R06: SPAG5; NbExp=3; IntAct=EBI-913476, EBI-413317; CC Q7Z460; P62258: YWHAE; NbExp=5; IntAct=EBI-913476, EBI-356498; CC Q7Z460; Q9JK25: Clip1; Xeno; NbExp=2; IntAct=EBI-913476, EBI-908338; CC Q7Z460; O55156: Clip2; Xeno; NbExp=3; IntAct=EBI-913476, EBI-349416; CC Q7Z460-2; Q9NX95-5: SYBU; NbExp=3; IntAct=EBI-10967515, EBI-12816095; CC Q7Z460-4; Q96AA8: JAKMIP2; NbExp=3; IntAct=EBI-10257534, EBI-752007; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, CC microtubule organizing center, centrosome CC {ECO:0000269|PubMed:14654843}. Chromosome, centromere, kinetochore. CC Cytoplasm, cytoskeleton, spindle. Golgi apparatus, trans-Golgi network CC {ECO:0000305}. Note=Localizes to microtubule plus ends. Localizes to CC centrosomes, kinetochores and the mitotic spindle from prometaphase. CC Subsequently localizes to the spindle midzone from anaphase and to the CC midbody from telophase. In migrating cells localizes to the plus ends CC of microtubules within the cell body and to the entire microtubule CC lattice within the lamella. Localizes to the cell cortex and this CC requires ERC1 and PHLDB2. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1; CC IsoId=Q7Z460-1; Sequence=Displayed; CC Name=2; CC IsoId=Q7Z460-2; Sequence=VSP_022386, VSP_022387, VSP_022389; CC Name=3; CC IsoId=Q7Z460-3; Sequence=VSP_022386, VSP_022387, VSP_022388, CC VSP_022389; CC Name=4; CC IsoId=Q7Z460-4; Sequence=VSP_054412, VSP_054413, VSP_022386, CC VSP_054414, VSP_022389; CC Name=5; CC IsoId=Q7Z460-5; Sequence=VSP_057272, VSP_022386, VSP_022387, CC VSP_022389; CC -!- SIMILARITY: Belongs to the CLASP family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH32563.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAX88872.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF347693; AAQ15051.1; -; mRNA. DR EMBL; AC012447; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC013399; AAX88872.1; ALT_SEQ; Genomic_DNA. DR EMBL; AC018737; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC079449; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC032563; AAH32563.1; ALT_INIT; mRNA. DR EMBL; BC112940; AAI12941.1; -; mRNA. DR EMBL; BC132723; AAI32724.1; -; mRNA. DR EMBL; BC144107; AAI44108.1; -; mRNA. DR EMBL; AJ288057; CAC35156.1; -; mRNA. DR EMBL; CR933722; CAI46251.1; -; mRNA. DR EMBL; AB014522; BAA31597.1; -; mRNA. DR CCDS; CCDS92851.1; -. [Q7Z460-2] DR CCDS; CCDS92852.1; -. [Q7Z460-1] DR CCDS; CCDS92854.1; -. [Q7Z460-4] DR PIR; T00387; T00387. DR RefSeq; NP_001135745.1; NM_001142273.1. [Q7Z460-5] DR RefSeq; NP_001135746.1; NM_001142274.1. [Q7Z460-2] DR RefSeq; NP_001193980.1; NM_001207051.1. [Q7Z460-4] DR RefSeq; NP_056097.1; NM_015282.2. [Q7Z460-1] DR RefSeq; XP_011509150.1; XM_011510848.1. [Q7Z460-3] DR PDB; 4K92; X-ray; 2.00 A; A/B=284-552. DR PDB; 6MQ5; X-ray; 2.15 A; A/B=1-257. DR PDB; 6MQ7; X-ray; 1.78 A; A/B=284-552. DR PDBsum; 4K92; -. DR PDBsum; 6MQ5; -. DR PDBsum; 6MQ7; -. DR AlphaFoldDB; Q7Z460; -. DR SMR; Q7Z460; -. DR BioGRID; 116919; 116. DR IntAct; Q7Z460; 53. DR MINT; Q7Z460; -. DR STRING; 9606.ENSP00000263710; -. DR DrugBank; DB12010; Fostamatinib. DR GlyCosmos; Q7Z460; 1 site, 1 glycan. DR GlyGen; Q7Z460; 4 sites, 1 O-linked glycan (4 sites). DR iPTMnet; Q7Z460; -. DR MetOSite; Q7Z460; -. DR PhosphoSitePlus; Q7Z460; -. DR SwissPalm; Q7Z460; -. DR BioMuta; CLASP1; -. DR DMDM; 74723323; -. DR EPD; Q7Z460; -. DR jPOST; Q7Z460; -. DR MassIVE; Q7Z460; -. DR MaxQB; Q7Z460; -. DR PaxDb; 9606-ENSP00000263710; -. DR PeptideAtlas; Q7Z460; -. DR ProteomicsDB; 24199; -. DR ProteomicsDB; 69152; -. [Q7Z460-1] DR ProteomicsDB; 69153; -. [Q7Z460-2] DR ProteomicsDB; 69154; -. [Q7Z460-3] DR ProteomicsDB; 7239; -. DR Pumba; Q7Z460; -. DR Antibodypedia; 33401; 332 antibodies from 32 providers. DR DNASU; 23332; -. DR Ensembl; ENST00000263710.8; ENSP00000263710.4; ENSG00000074054.21. [Q7Z460-1] DR Ensembl; ENST00000409078.8; ENSP00000386442.3; ENSG00000074054.21. [Q7Z460-2] DR Ensembl; ENST00000541377.5; ENSP00000441625.1; ENSG00000074054.21. [Q7Z460-4] DR GeneID; 23332; -. DR KEGG; hsa:23332; -. DR UCSC; uc061nlf.1; human. [Q7Z460-1] DR AGR; HGNC:17088; -. DR CTD; 23332; -. DR DisGeNET; 23332; -. DR GeneCards; CLASP1; -. DR HGNC; HGNC:17088; CLASP1. DR HPA; ENSG00000074054; Low tissue specificity. DR MalaCards; CLASP1; -. DR MIM; 605852; gene. DR neXtProt; NX_Q7Z460; -. DR OpenTargets; ENSG00000074054; -. DR PharmGKB; PA38436; -. DR VEuPathDB; HostDB:ENSG00000074054; -. DR eggNOG; KOG2956; Eukaryota. DR GeneTree; ENSGT00940000154817; -. DR InParanoid; Q7Z460; -. DR OMA; LMEHKVQ; -. DR OrthoDB; 5478662at2759; -. DR PhylomeDB; Q7Z460; -. DR TreeFam; TF101155; -. DR PathwayCommons; Q7Z460; -. DR Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal. DR Reactome; R-HSA-2467813; Separation of Sister Chromatids. DR Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion. DR Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition. DR Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes. DR Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes. DR Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome. DR Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes. DR Reactome; R-HSA-428890; Role of ABL in ROBO-SLIT signaling. DR Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane. DR Reactome; R-HSA-5663220; RHO GTPases Activate Formins. DR Reactome; R-HSA-68877; Mitotic Prometaphase. DR Reactome; R-HSA-8854518; AURKA Activation by TPX2. DR Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation. DR SignaLink; Q7Z460; -. DR SIGNOR; Q7Z460; -. DR BioGRID-ORCS; 23332; 19 hits in 398 CRISPR screens. DR ChiTaRS; CLASP1; human. DR GeneWiki; CLASP1; -. DR GenomeRNAi; 23332; -. DR Pharos; Q7Z460; Tbio. DR PRO; PR:Q7Z460; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q7Z460; Protein. DR Bgee; ENSG00000074054; Expressed in cortical plate and 203 other cell types or tissues. DR ExpressionAtlas; Q7Z460; baseline and differential. DR GO; GO:0045180; C:basal cortex; IDA:UniProtKB. DR GO; GO:0005938; C:cell cortex; IDA:MGI. DR GO; GO:0031592; C:centrosomal corona; IDA:UniProtKB. DR GO; GO:0005813; C:centrosome; IDA:UniProtKB. DR GO; GO:0030981; C:cortical microtubule cytoskeleton; IDA:UniProtKB. DR GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB. DR GO; GO:0000776; C:kinetochore; IDA:UniProtKB. DR GO; GO:0005828; C:kinetochore microtubule; TAS:UniProtKB. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central. DR GO; GO:0035371; C:microtubule plus-end; ISS:UniProtKB. DR GO; GO:0072686; C:mitotic spindle; IBA:GO_Central. DR GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB. DR GO; GO:0002162; F:dystroglycan binding; IPI:UniProtKB. DR GO; GO:0043515; F:kinetochore binding; IMP:UniProtKB. DR GO; GO:0008017; F:microtubule binding; IDA:UniProtKB. DR GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB. DR GO; GO:0030953; P:astral microtubule organization; IMP:UniProtKB. DR GO; GO:0051301; P:cell division; IDA:MGI. DR GO; GO:0090162; P:establishment of epithelial cell polarity; ISS:UniProtKB. DR GO; GO:0040001; P:establishment of mitotic spindle localization; IMP:UniProtKB. DR GO; GO:0051294; P:establishment of spindle orientation; IDA:MGI. DR GO; GO:0007163; P:establishment or maintenance of cell polarity; NAS:UniProtKB. DR GO; GO:0010458; P:exit from mitosis; IMP:UniProtKB. DR GO; GO:0007030; P:Golgi organization; IMP:UniProtKB. DR GO; GO:0034453; P:microtubule anchoring; IMP:UniProtKB. DR GO; GO:0001578; P:microtubule bundle formation; IMP:UniProtKB. DR GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB. DR GO; GO:0007020; P:microtubule nucleation; IMP:UniProtKB. DR GO; GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB. DR GO; GO:0090307; P:mitotic spindle assembly; ISS:UniProtKB. DR GO; GO:0007052; P:mitotic spindle organization; IMP:UniProtKB. DR GO; GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB. DR GO; GO:0031111; P:negative regulation of microtubule polymerization or depolymerization; IMP:UniProtKB. DR GO; GO:0051497; P:negative regulation of stress fiber assembly; IMP:UniProtKB. DR GO; GO:1903690; P:negative regulation of wound healing, spreading of epidermal cells; IMP:UniProtKB. DR GO; GO:1904261; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; IMP:UniProtKB. DR GO; GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB. DR GO; GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB. DR GO; GO:0090091; P:positive regulation of extracellular matrix disassembly; IMP:UniProtKB. DR GO; GO:0031116; P:positive regulation of microtubule polymerization; ISS:UniProtKB. DR GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; IMP:UniProtKB. DR GO; GO:0051893; P:regulation of focal adhesion assembly; IMP:UniProtKB. DR GO; GO:0010470; P:regulation of gastrulation; IMP:UniProtKB. DR GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IGI:UniProtKB. DR GO; GO:0006903; P:vesicle targeting; IMP:UniProtKB. DR Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 4. DR InterPro; IPR011989; ARM-like. DR InterPro; IPR016024; ARM-type_fold. DR InterPro; IPR024395; CLASP_N_dom. DR InterPro; IPR021133; HEAT_type_2. DR InterPro; IPR034085; TOG. DR InterPro; IPR048491; XMAP215_CLASP_TOG. DR PANTHER; PTHR21567; CLASP; 1. DR PANTHER; PTHR21567:SF28; CLIP-ASSOCIATING PROTEIN 1; 1. DR Pfam; PF21040; CEP104-like_TOG; 1. DR Pfam; PF12348; CLASP_N; 1. DR Pfam; PF21041; XMAP215_CLASP_TOG; 1. DR SMART; SM01349; TOG; 4. DR SUPFAM; SSF48371; ARM repeat; 2. DR PROSITE; PS50077; HEAT_REPEAT; 1. DR Genevisible; Q7Z460; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell cycle; Cell division; Centromere; KW Chromosome; Coiled coil; Cytoplasm; Cytoskeleton; Golgi apparatus; KW Kinetochore; Microtubule; Mitosis; Phosphoprotein; Reference proteome; KW Repeat. FT CHAIN 1..1538 FT /note="CLIP-associating protein 1" FT /id="PRO_0000089847" FT REPEAT 87..124 FT /note="HEAT 1" FT REPEAT 163..200 FT /note="HEAT 2" FT REPEAT 405..440 FT /note="HEAT 3" FT REPEAT 441..477 FT /note="HEAT 4" FT REPEAT 974..1011 FT /note="HEAT 5" FT REPEAT 1342..1379 FT /note="HEAT 6" FT REPEAT 1460..1497 FT /note="HEAT 7" FT REGION 235..292 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 543..783 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 662..785 FT /note="Interaction with microtubules, MAPRE1 and MAPRE3" FT /evidence="ECO:0000269|PubMed:15631994" FT REGION 1080..1120 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1136..1156 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1215..1238 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1254..1538 FT /note="Interaction with CLIP2" FT /evidence="ECO:0000250" FT REGION 1254..1538 FT /note="Interaction with PHLDB2 and RSN" FT /evidence="ECO:0000269|PubMed:16824950" FT REGION 1256..1538 FT /note="Localization to kinetochores" FT COILED 1299..1330 FT /evidence="ECO:0000255" FT COMPBIAS 250..288 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 543..627 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 639..691 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 706..755 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 246 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 545 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 548 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q80TV8" FT MOD_RES 558 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 559 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 568 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 600 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692, FT ECO:0007744|PubMed:23186163" FT MOD_RES 636 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 646 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163" FT MOD_RES 647 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 649 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 656 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 684 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692" FT MOD_RES 688 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332" FT MOD_RES 695 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 705 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 711 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 714 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 787 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 797 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:19690332, FT ECO:0007744|PubMed:23186163" FT MOD_RES 823 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 1091 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163" FT MOD_RES 1095 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q80TV8" FT MOD_RES 1099 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 1113 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q80TV8" FT MOD_RES 1196 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18088087, FT ECO:0007744|PubMed:23186163" FT MOD_RES 1223 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT VAR_SEQ 637 FT /note="L -> LESRHMREDMEYIGLDS (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_054412" FT VAR_SEQ 637 FT /note="L -> LDGTTTKAE (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_057272" FT VAR_SEQ 673..682 FT /note="RSRSANPAGA -> P (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_054413" FT VAR_SEQ 737..772 FT /note="Missing (in isoform 2, isoform 3, isoform 4 and FT isoform 5)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17974005" FT /id="VSP_022386" FT VAR_SEQ 808 FT /note="L -> LLLGDSRSK (in isoform 2, isoform 3 and isoform FT 5)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17974005" FT /id="VSP_022387" FT VAR_SEQ 808 FT /note="L -> LLLGDSRS (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_054414" FT VAR_SEQ 911 FT /note="K -> KIADSEAECEDKEGNLFPSEVSCT (in isoform 3)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_022388" FT VAR_SEQ 1123..1161 FT /note="Missing (in isoform 2, isoform 3, isoform 4 and FT isoform 5)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17974005" FT /id="VSP_022389" FT VARIANT 233 FT /note="I -> T (in dbSNP:rs17761055)" FT /id="VAR_053818" FT CONFLICT 251 FT /note="R -> G (in Ref. 5; CAI46251)" FT /evidence="ECO:0000305" FT CONFLICT 556 FT /note="S -> F (in Ref. 5; CAI46251)" FT /evidence="ECO:0000305" FT HELIX 5..13 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 17..32 FT /evidence="ECO:0007829|PDB:6MQ5" FT TURN 34..42 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 44..56 FT /evidence="ECO:0007829|PDB:6MQ5" FT TURN 57..60 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 64..81 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 82..85 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 86..99 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 105..121 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 125..130 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 133..137 FT /evidence="ECO:0007829|PDB:6MQ5" FT STRAND 138..140 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 141..158 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 160..162 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 165..176 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 181..198 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 200..207 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 213..228 FT /evidence="ECO:0007829|PDB:6MQ5" FT HELIX 296..305 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 317..331 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 338..353 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 356..358 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 362..367 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 370..377 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 382..399 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 400..403 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 404..415 FT /evidence="ECO:0007829|PDB:6MQ7" FT TURN 416..419 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 423..439 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 445..450 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 451..454 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 458..474 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 477..479 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 481..483 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 484..495 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 500..516 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 518..525 FT /evidence="ECO:0007829|PDB:6MQ7" FT HELIX 530..537 FT /evidence="ECO:0007829|PDB:6MQ7" SQ SEQUENCE 1538 AA; 169451 MW; 6E03BD948C227F8D CRC64; MEPRMESCLA QVLQKDVGKR LQVGQELIDY FSDKQKSADL EHDQTMLDKL VDGLATSWVN SSNYKVVLLG MDILSALVTR LQDRFKAQIG TVLPSLIDRL GDAKDSVREQ DQTLLLKIMD QAANPQYVWD RMLGGFKHKN FRTREGICLC LIATLNASGA QTLTLSKIVP HICNLLGDPN SQVRDAAINS LVEIYRHVGE RVRADLSKKG LPQSRLNVIF TKFDEVQKSG NMIQSANDKN FDDEDSVDGN RPSSASSTSS KAPPSSRRNV GMGTTRRLGS STLGSKSSAA KEGAGAVDEE DFIKAFDDVP VVQIYSSRDL EESINKIREI LSDDKHDWEQ RVNALKKIRS LLLAGAAEYD NFFQHLRLLD GAFKLSAKDL RSQVVREACI TLGHLSSVLG NKFDHGAEAI MPTIFNLIPN SAKIMATSGV VAVRLIIRHT HIPRLIPVIT SNCTSKSVAV RRRCFEFLDL LLQEWQTHSL ERHISVLAET IKKGIHDADS EARIEARKCY WGFHSHFSRE AEHLYHTLES SYQKALQSHL KNSDSIVSLP QSDRSSSSSQ ESLNRPLSAK RSPTGSTTSR ASTVSTKSVS TTGSLQRSRS DIDVNAAASA KSKVSSSSGT TPFSSAAALP PGSYASLGRI RTRRQSSGSA TNVASTPDNR GRSRAKVVSQ SQRSRSANPA GAGSRSSSPG KLLGSGYGGL TGGSSRGPPV TPSSEKRSKI PRSQGCSRET SPNRIGLARS SRIPRPSMSQ GCSRDTSRES SRDTSPARGF PPLDRFGLGQ PGRIPGSVNA MRVLSTSTDL EAAVADALKK PVRRRYEPYG MYSDDDANSD ASSVCSERSY GSRNGGIPHY LRQTEDVAEV LNHCASSNWS ERKEGLLGLQ NLLKSQRTLS RVELKRLCEI FTRMFADPHS KRVFSMFLET LVDFIIIHKD DLQDWLFVLL TQLLKKMGAD LLGSVQAKVQ KALDVTRDSF PFDQQFNILM RFIVDQTQTP NLKVKVAILK YIESLARQMD PTDFVNSSET RLAVSRIITW TTEPKSSDVR KAAQIVLISL FELNTPEFTM LLGALPKTFQ DGATKLLHNH LKNSSNTSVG SPSNTIGRTP SRHTSSRTSP LTSPTNCSHG GLSPSRLWGW SADGLAKHPP PFSQPNSIPT APSHKALRRS YSPSMLDYDT ENLNSEEIYS SLRGVTEAIE KFSFRSQEDL NEPIKRDGKK ECDIVSRDGG AASPATEGRG GSEVEGGRTA LDNKTSLLNT QPPRAFPGPR ARDYNPYPYS DAINTYDKTA LKEAVFDDDM EQLRDVPIDH SDLVADLLKE LSNHNERVEE RKGALLELLK ITREDSLGVW EEHFKTILLL LLETLGDKDH SIRALALRVL REILRNQPAR FKNYAELTIM KTLEAHKDSH KEVVRAAEEA ASTLASSIHP EQCIKVLCPI IQTADYPINL AAIKMQTKVV ERIAKESLLQ LLVDIIPGLL QGYDNTESSV RKASVFCLVA IYSVIGEDLK PHLAQLTGSK MKLLNLYIKR AQTTNSNSSS SSDVSTHS //